Roles	NNS
for	IN
insulin-like-growth-factor-I	NN
and	CC
transforming-growth-factor-beta	NN
in	IN
fibrotic	JJ
lung	NN
disease	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
lung	NN
disease	NN
that	WDT
is	VBZ
characterized	VBN
by	IN
epithelial	JJ
cell	NN
damage	NN
and	CC
areas	NNS
of	IN
denuded	JJ
basement	NN
membrane	NN
resulting	VBG
in	IN
inflammation	NN
,	,
fibroblast	NN
proliferation	NN
,	,
excessive	JJ
extracellular	JJ
matrix	NN
(	(
ECM	NN
)	)
deposition	NN
,	,
and	CC
remodeling	NN
of	IN
alveolar	JJ
gas	NN
exchange	NN
units	NNS
.	.

The	DT
progressive	JJ
loss	NN
of	IN
lung	NN
gas	NN
exchange	NN
units	NNS
in	IN
patients	NNS
with	IN
IPF	NN
leads	VBZ
to	TO
respiratory	JJ
failure	NN
and	CC
eventually	RB
to	TO
death	NN
.	.

While	IN
the	DT
etiology	NN
of	IN
this	DT
disease	NN
is	VBZ
unknown	JJ
,	,
for	IN
many	JJ
years	NNS
studies	NNS
suggested	VBD
that	IN
chronic	JJ
inflammation	NN
was	VBD
the	DT
underlying	JJ
factor	NN
that	WDT
caused	VBD
fibroproliferation	NN
and	CC
structural	JJ
alterations	NNS
of	IN
the	DT
lung	NN
.	.

Recent	JJ
data	NNS
show	VBP
that	IN
fibroproliferation	NN
and	CC
fibrosis	NN
can	MD
occur	VB
independently	RB
of	IN
inflammation	NN
,	,
suggesting	VBG
that	IN
IPF	NN
is	VBZ
a	DT
disease	NN
caused	VBN
by	IN
a	DT
mesenchymal	JJ
,	,
rather	RB
than	IN
an	DT
immune	JJ
disorder	NN
.	.

Mesenchymal	JJ
growth	NN
factors	NNS
,	,
including	VBG
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
beta	NN
,	,
insulin-like	JJ
growth	NN
factor	NN
(	(
IGF	NN
)	)
-	:
I	PRP
,	,
platelet-derived	JJ
growth	NN
factor	NN
,	,
connective-tissue-growth-factor	NN
,	,
fibroblast	NN
growth	NN
factors	NNS
,	,
and	CC
keratinocyte	NN
growth	NN
factors	NNS
,	,
as	RB
well	RB
as	IN
proinflammatory	JJ
cytokines	NNS
such	JJ
as	IN
tumor-necrosis-factor-alpha	NN
and	CC
interleukin-1beta	NN
,	,
have	VBP
been	VBN
shown	VBN
to	TO
be	VB
exaggerated	VBN
in	IN
several	JJ
fibrotic	JJ
lung	NN
disorders	NNS
including	VBG
IPF	NN
,	,
ARDS	NN
,	,
sarcoidosis	NN
,	,
and	CC
bronchopulmonary	JJ
dysplasia	NN
,	,
as	RB
well	RB
as	IN
pulmonary	JJ
manifestations	NNS
of	IN
systemic	JJ
diseases	NNS
such	JJ
as	IN
rheumatoid	JJ
arthritis	NN
or	CC
progressive	JJ
systemic	JJ
sclerosis	NN
(	(
scleroderma	NN
)	)
.	.

We	PRP
argue	VBP
that	IN
inflammation	NN
is	VBZ
required	VBN
to	TO
initiate	VB
growth	NN
factor	NN
production	NN
and	CC
repair	NN
of	IN
the	DT
damaged	VBN
alveolar	JJ
epithelial	JJ
lining	NN
in	IN
fibrotic	JJ
lung	NN
diseases	NNS
and	CC
that	IN
exaggerated	JJ
TGF-beta	NN
production	NN
may	MD
be	VB
responsible	JJ
for	IN
the	DT
fibrotic	JJ
response	NN
seen	VBN
in	IN
diseases	NNS
such	JJ
as	IN
IPF	NN
.	.

We	PRP
recognize	VBP
the	DT
potential	JJ
role	NN
of	IN
several	JJ
growth	NN
factors	NNS
in	IN
the	DT
fibroproliferative	JJ
process	NN
in	IN
the	DT
lung	NN
,	,
and	CC
in	IN
this	DT
brief	JJ
report	NN
we	PRP
focus	VBP
on	IN
the	DT
possible	JJ
roles	NNS
of	IN
the	DT
growth	NN
factors	NNS
IGF-I	NN
and	CC
TGF-beta	NN
in	IN
cell	NN
migration	NN
,	,
proliferation	NN
,	,
and	CC
ECM	NN
synthesis	NN
in	IN
patients	NNS
with	IN
IPF	NN
.	.

